| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 58,575 | 62,744 | 74,481 | 155,399 | | Cost of Revenue | 35,651 | 34,215 | 56,610 | 99,134 | | | Gross Profit | 22,924 | 28,529 | 17,871 | 56,265 | | | Operating Expenses | | Research Development | 17,321 | 13,710 | 11,215 | 13,802 | | Selling General and Administrative | 9,755 | 10,242 | 10,209 | 13,429 | | Non Recurring |
-
|
-
|
-
| 54,450 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,152) | 4,577 | (3,553) | (25,416) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 916 | (1,007) | (484) | 5,178 | | Earnings Before Interest And Taxes | (4,085) | 3,570 | (4,037) | (20,238) | | Interest Expense | (884) | 81 | 803 | 369 | | Income Before Tax | (3,201) | 3,489 | (4,840) | (20,607) | | Income Tax Expense | (1,094) | 69 | 48 | 85 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,107) | 3,420 | (4,888) | (20,692) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,107) | 3,420 | (4,888) | (20,692) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,107) | $3,420 | ($4,888) | ($20,692) |
|
0.63% Nasdaq 
0.03%
Income Statement
